Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lutyńska A[au]:

Aluminium-adjuvanted vaccines--a review of the current state of knowledge. Gołoś A et al. Przegl Epidemiol. (2015)

Global phylogeography and evolutionary history of Shigella dysenteriae type 1. Njamkepo E et al. Nat Microbiol. (2016)

The safety and effectiveness of vaccination against influenza and pertussis in pregnant women Augustynowicz E et al. Przegl Epidemiol. (2017)

Search results

Items: 42

1.

microRNA expression profile in Smooth Muscle Cells isolated from thoracic aortic aneurysm samples.

Kasprzyk-Pawelec A, Wojciechowska A, Kuc M, Zielinski J, Parulski A, Kusmierczyk M, Lutynska A, Kozar-Kaminska K.

Adv Med Sci. 2019 Apr 22;64(2):331-337. doi: 10.1016/j.advms.2019.04.003. [Epub ahead of print]

PMID:
31022558
2.

Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.

Polak M, Zasada AA, Mosiej E, Krysztopa-Grzybowska K, Witkowski L, Rzeczkowska M, Piekarska K, Lutyńska A.

Microbes Infect. 2018 Dec 21. pii: S1286-4579(18)30193-X. doi: 10.1016/j.micinf.2018.12.001. [Epub ahead of print]

PMID:
30580013
3.

Sudden cardiac arrest in patients without overt heart disease: a limited value of next generation sequencing.

Stępień-Wojno M, Ponińska J, Rydzanicz M, Bilińska M, Truszkowska G, Baranowski R, Lutyńska A, Biernacka EK, Stępińska J, Kowalik I, Płoski R, Bilińska ZT.

Pol Arch Intern Med. 2018 Dec 21;128(12):721-730. doi: 10.20452/pamw.4366. Epub 2018 Nov 7.

4.

MLST and RAPD molecular analysis of Staphylococcus aureus subsp. anaerobius isolated from goats in Poland.

Szaluś-Jordanow O, Krysztopa-Grzybowska K, Czopowicz M, Moroz A, Mickiewicz M, Lutyńska A, Kaba J, Nalbert T, Frymus T.

Arch Microbiol. 2018 Nov;200(9):1407-1410. doi: 10.1007/s00203-018-1568-1. Epub 2018 Sep 4.

5.

Extremely Strong Halogen Bond. The Case of a Double-Charge-Assisted Halogen Bridge.

Domagała M, Lutyńska A, Palusiak M.

J Phys Chem A. 2018 Jun 21;122(24):5484-5492. doi: 10.1021/acs.jpca.8b03735. Epub 2018 Jun 8.

PMID:
29809012
6.

Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance.

Gawor M, Śpiewak M, Kubik A, Wróbel A, Lutyńska A, Marczak M, Grzybowski J.

Biomarkers. 2018 Nov;23(7):676-682. doi: 10.1080/1354750X.2018.1474261. Epub 2018 May 23.

PMID:
29737871
7.

The safety and effectiveness of vaccination against influenza and pertussis in pregnant women

Augustynowicz E, Lutyńska A, Piotrowska A, Paradowska- Stankiewicz I.

Przegl Epidemiol. 2017;71(1):55-67.

8.

Multi-locus variable-number tandem repeat analysis of Bordetella pertussis isolates circulating in Poland in the period 1959-2013.

Mosiej E, Krysztopa-Grzybowska K, Polak M, Prygiel M, Lutyńska A.

J Med Microbiol. 2017 Jun;66(6):753-761. doi: 10.1099/jmm.0.000408. Epub 2017 Jun 9.

PMID:
28598302
9.

The importance of Bordetella pertussis strains which do not produce virulence factors in the epidemiology of pertussis.

Polak M, Lutyńska A.

Postepy Hig Med Dosw (Online). 2017 May 9;71(0):367-379. Review.

10.

Microevolution of BCG substrains.

Krysztopa-Grzybowska K, Lutyńska A.

Postepy Hig Med Dosw (Online). 2016 Dec 21;70(0):1259-1266. Review.

11.

Erratum: Global phylogeography and evolutionary history of Shigella dysenteriae type 1.

Njamkepo E, Fawal N, Tran-Dien A, Hawkey J, Strockbine N, Jenkins C, Talukder KA, Bercion R, Kuleshov K, Kolínská R, Russell JE, Kaftyreva L, Accou-Demartin M, Karas A, Vandenberg O, Mather AE, Mason CJ, Page AJ, Ramamurthy T, Bizet C, Gamian A, Carle I, Sow AG, Bouchier C, Wester AL, Lejay-Collin M, Fonkoua MC, Le Hello S, Blaser MJ, Jernberg C, Ruckly C, Mérens A, Page AL, Aslett M, Roggentin P, Fruth A, Denamur E, Venkatesan M, Bercovier H, Bodhidatta L, Chiou CS, Clermont D, Colonna B, Egorova S, Pazhani GP, Ezernitchi AV, Guigon G, Harris SR, Izumiya H, Korzeniowska-Kowal A, Lutyńska A, Gouali M, Grimont F, Langendorf C, Marejková M, Peterson LA, Perez-Perez G, Ngandjio A, Podkolzin A, Souche E, Makarova M, Shipulin GA, Ye C, Žemličková H, Herpay M, Grimont PA, Parkhill J, Sansonetti P, Holt KE, Brisse S, Thomson NR, Weill FX.

Nat Microbiol. 2016 Oct 3;1(11):16209. doi: 10.1038/nmicrobiol.2016.209. No abstract available.

PMID:
27694821
12.

Global phylogeography and evolutionary history of Shigella dysenteriae type 1.

Njamkepo E, Fawal N, Tran-Dien A, Hawkey J, Strockbine N, Jenkins C, Talukder KA, Bercion R, Kuleshov K, Kolínská R, Russell JE, Kaftyreva L, Accou-Demartin M, Karas A, Vandenberg O, Mather AE, Mason CJ, Page AJ, Ramamurthy T, Bizet C, Gamian A, Carle I, Sow AG, Bouchier C, Wester AL, Lejay-Collin M, Fonkoua MC, Le Hello S, Blaser MJ, Jernberg C, Ruckly C, Mérens A, Page AL, Aslett M, Roggentin P, Fruth A, Denamur E, Venkatesan M, Bercovier H, Bodhidatta L, Chiou CS, Clermont D, Colonna B, Egorova S, Pazhani GP, Ezernitchi AV, Guigon G, Harris SR, Izumiya H, Korzeniowska-Kowal A, Lutyńska A, Gouali M, Grimont F, Langendorf C, Marejková M, Peterson LA, Perez-Perez G, Ngandjio A, Podkolzin A, Souche E, Makarova M, Shipulin GA, Ye C, Žemličková H, Herpay M, Grimont PA, Parkhill J, Sansonetti P, Holt KE, Brisse S, Thomson NR, Weill FX.

Nat Microbiol. 2016 Mar 21;1:16027. doi: 10.1038/nmicrobiol.2016.27. Erratum in: Nat Microbiol. 2016 Oct 03;1(11):16209.

PMID:
27572446
13.

Thiomersal-containing vaccines - a review of the current state of knowledge.

Gołoś A, Lutyńska A.

Przegl Epidemiol. 2015;69(1):59-64, 157-61. Review. English, Polish.

14.

Aluminium-adjuvanted vaccines--a review of the current state of knowledge.

Gołoś A, Lutyńska A.

Przegl Epidemiol. 2015;69(4):731-4, 871-4. Review. English, Polish.

15.

[Susceptibility of Lactobacillus rhamnosus strains isolated from probiotic products to antimicrobial agents].

Wiatrzyk A, Polak M, Krysztopa-Grzybowska K, Czajka U, Lutyńska A.

Med Dosw Mikrobiol. 2015;67(3-4):195-206. Polish.

PMID:
27019914
16.

PCR-based genomic deletion analysis of RD-regions in the identification of mycobacteria isolated from adverse events following BCG vaccination or TB suspected cases.

Krysztopa-Grzybowska K, Brzezińska S, Augustynowicz-Kopeć E, Augustynowicz E, Lutyńska A.

Pol J Microbiol. 2014;63(3):359-62.

17.

Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.

van Gent M, Heuvelman CJ, van der Heide HG, Hallander HO, Advani A, Guiso N, Wirsing von Kőnig CH, Vestrheim DF, Dalby T, Fry NK, Pierard D, Detemmerman L, Zavadilova J, Fabianova K, Logan C, Habington A, Byrne M, Lutyńska A, Mosiej E, Pelaz C, Gröndahl-Yli-Hannuksela K, Barkoff AM, Mertsola J, Economopoulou A, He Q, Mooi FR.

Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):821-30. doi: 10.1007/s10096-014-2297-2. Epub 2014 Dec 20.

18.

Effectiveness of experimental whole-cell pertussis vaccines in murine model.

Polak M, Zawadka M, Mosiej E, Rabczenko D, Augustynowicz E, Lutyńska A.

Med Dosw Mikrobiol. 2014;66(2):79-87.

PMID:
25369654
19.

Colonization of Bordetella pertussis clinical isolates that differ by pulsed field gel electrophoresis types in the lungs of naïve mice or mice immunized with the whole-cell pertussis vaccine used in Poland.

Polak M, Zawadka M, Mosiej E, Rabczenko D, Augustynowicz E, Guiso N, Lutyńska A.

Arch Immunol Ther Exp (Warsz). 2015 Apr;63(2):155-60. doi: 10.1007/s00005-014-0314-x. Epub 2014 Oct 9.

PMID:
25297678
20.

Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.

Mosiej E, Zawadka M, Krysztopa-Grzybowska K, Polak M, Augustynowicz E, Piekarska K, Lutyńska A.

Eur J Clin Microbiol Infect Dis. 2015 Jan;34(1):147-152. doi: 10.1007/s10096-014-2216-6. Epub 2014 Aug 5.

PMID:
25090968
21.

Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction.

Sadowska-Krawczenko I, Paprzycka M, Korbal P, Wiatrzyk A, Krysztopa-Grzybowska K, Polak M, Czajka U, Lutyńska A.

Benef Microbes. 2014 Dec;5(4):397-402. doi: 10.3920/BM2013.0074.

PMID:
25035097
22.

[Advances in the development of new vaccines against tuberculosis. 100 years after the introduction of BCG].

Krysztopa-Grzybowska K, Lutyńska A.

Postepy Hig Med Dosw (Online). 2014 Jun 9;68:768-76. Review. Polish.

23.

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.

Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutyńska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR.

MBio. 2014 Apr 22;5(2):e01074. doi: 10.1128/mBio.01074-14.

24.

Consistency of Bordetella pertussis vaccine seed strains and potency of whole-cell pertussis vaccine still in use in Poland.

Zawadka M, Mosiej E, Polak M, Krysztopa-Grzybowska K, Moskała B, Rokosz-Chudziak N, Rabczenko D, Augustynowicz E, Lutyńska A.

Biologicals. 2014 Mar;42(2):123-7. doi: 10.1016/j.biologicals.2013.11.006. Epub 2014 Jan 20.

PMID:
24457195
25.

[Reproducibility of Fim2 and Fim3 antigens determination in Bordetella pertussis by serotyping method].

Zawadka M, Moskala B, Letowska I, Mosiej E, Krysztopa-Grzybowska K, Lutyńska A.

Med Dosw Mikrobiol. 2013;65(3):171-9. Polish.

PMID:
24432556
26.

[Evaluation of Bordetella pertussis strains toxicity in vitro using CHO cell lines].

Zawadka M, Rabczenko D, Lutyńska A.

Med Dosw Mikrobiol. 2014;66(3-4):185-94. Polish.

PMID:
25804072
27.

[Phenotypic and genotypic characterization of probiotic bacterial strains used in medicinal products].

Wiatrzyk A, Polak M, Czajka U, Krysztopa-Grzybowska K, Lutyńska A.

Med Dosw Mikrobiol. 2013;65(1):47-56. Polish.

PMID:
24180131
28.

[The studies of elimination of nontypeable Haemophilus influenzae strains using the animal model of infection].

Augustynowicz E, Zawadka M, Wiatrzyk A, Rabczenko D, Lutyńska A.

Med Dosw Mikrobiol. 2013;65(1):1-10. Polish.

PMID:
24180126
29.

Multiplex-PCR as an identity assay for Mycobacterium bovis BCG Moreau descendants.

Krysztopa-Grzybowska K, Brzezińska S, Augustynowicz-Kopeć E, Polak M, Lutyńska A.

Biologicals. 2013 May;41(3):197-200. doi: 10.1016/j.biologicals.2012.12.002. Epub 2013 Mar 13.

PMID:
23490534
30.

Mechanism of Vipera berus venom activity and the principles of antivenom administration in treatment.

Czajka U, Wiatrzyk A, Lutyńska A.

Przegl Epidemiol. 2013;67(4):641-6, 729-33. Review. English, Polish.

31.

The rate of adverse events following BCG vaccination in Poland.

Krysztopa-Grzybowska K, Paradowska-Stankiewicz I, Lutyńska A.

Przegl Epidemiol. 2012;66(3):465-9.

32.

Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009.

Advani A, Hallander HO, Dalby T, Krogfelt KA, Guiso N, Njamkepo E, von Könnig CH, Riffelmann M, Mooi FR, Sandven P, Lutynska A, Fry NK, Mertsola J, He Q.

J Clin Microbiol. 2013 Feb;51(2):422-8. doi: 10.1128/JCM.02036-12. Epub 2012 Nov 21.

33.

PFGE and AFLP genotyping of Staphylococcus aureus subsp. anaerobius isolated from goats with Morel's disease.

Szaluś-Jordanow O, Chrobak D, Pyrgiel M, Lutyńska A, Kaba J, Czopowicz M, Witkowski L, Kizerwetter-Świda M, Binek M, Frymus T.

Arch Microbiol. 2013 Jan;195(1):37-41. doi: 10.1007/s00203-012-0844-8. Epub 2012 Sep 14.

34.

Descendant of daughter Brazilian BCG Moreau substrain in Poland.

Krysztopa-Grzybowska K, Brzezińska S, Augustynowicz-Kopeć E, Polak M, Augustynowicz E, Lutyńska A.

Vaccine. 2012 Aug 10;30(37):5512-8. doi: 10.1016/j.vaccine.2012.06.056. Epub 2012 Jun 27.

PMID:
22749596
35.

[Initiative of introducing the applications of genetics for public health purposes in Poland].

Lutyńska A, Krzysztof K, Wysocki MJ.

Przegl Epidemiol. 2012;66(1):113-7. Review. Polish.

36.
37.
38.

[Detection of the adventitious agents in the evaluation of vaccine safety].

Augustynowicz E, Lutyńska A.

Przegl Epidemiol. 2012;66(4):643-9. Polish.

39.

Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries.

Kallonen T, Gröndahl-Yli-Hannuksela K, Elomaa A, Lutyńska A, Fry NK, Mertsola J, He Q.

Infect Genet Evol. 2011 Dec;11(8):2034-42. doi: 10.1016/j.meegid.2011.09.012. Epub 2011 Sep 21.

PMID:
21964035
40.

[Immunization of adolescents and adults as the strategy of improvement of epidemiology of pertussis].

Lutyńska A, Wiatrzyk A, Mosiej E, Zawadka M.

Przegl Epidemiol. 2011;65(1):45-50. Polish.

PMID:
21735835
41.

Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.

Zawadka M, Polak M, Rabczenko D, Mosiej E, Augustynowicz E, Lutyńska A.

Vaccine. 2011 Jul 26;29(33):5488-94. doi: 10.1016/j.vaccine.2011.05.053. Epub 2011 Jun 12.

PMID:
21641954
42.

Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use.

Mosiej E, Augustynowicz E, Zawadka M, Dabrowski W, Lutyńska A.

J Clin Microbiol. 2011 Apr;49(4):1452-7. doi: 10.1128/JCM.01487-10. Epub 2011 Feb 9.

Supplemental Content

Loading ...
Support Center